Provided by Tiger Trade Technology Pte. Ltd.

Global X Genomics & Biotechnology ETF

63.57
+1.352.17%
Post-market: 63.40-0.1689-0.27%19:42 EDT
Volume:11.27K
Turnover:710.22K
Market Cap:95.65M
PE:- -
High:63.76
Open:62.31
Low:62.22
Close:62.22
52wk High:68.00
52wk Low:36.13
Shares:1.50M
Float Shares:1.50M
Volume Ratio:0.23
T/O Rate:0.75%
Dividend:0.65
Dividend Rate:1.02%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Natera announces publication of new data in Blood Neoplasia on Signatera

TIPRANKS
·
Sep 01

Top 10 Best-Performing US Stocks in August: Moderna Surges 156%, Palantir Leads AI Software Stocks

TradingKey
·
Sep 01

Circio boosts circVec gene therapy data and secures funding runway to 2030

TIPRANKS
·
Sep 01

Cboe data suggests bullish flow in Moderna with shares up 0.71%

TIPRANKS
·
Sep 01

Moderna Stock (MRNA) Was the Best Performer in August

TIPRANKS
·
Sep 01

CytoDyn Net Loss Widens to $42.7 Million in FY26

Reuters
·
Aug 31

Does Guardant Health’s (GH) Patent Appeal Reshape Its Competitive Moat More Than Its Royalty Bill?

Simply Wall St.
·
Aug 30

August Turmoil: Bessent's Intervention and the Quiet Reveal of Policy's Hidden Hand

Deep News
·
Aug 30

Charles Schwab, Tonix, Boston Scientific, Alcoa, Illumina

TIPRANKS
·
Aug 29

Pharma Industry Stares Down Biggest Patent Cliff in Decades

Dow Jones
·
Aug 29

US Stocks Weekly: AI Refuel

Reuters
·
Aug 29

BioNTech Stock Falls on Cancer Vaccine Setback Days After Moderna's Big Win

Dow Jones
·
Aug 29

BioNTech on Track for Worst Day Since March After Ending Colorectal Cancer Trial

Reuters
·
Aug 29

Natera and Susan G. Komen® Announce National Partnership to Accelerate Progress Against Breast Cancer

THOMSON REUTERS
·
Aug 28

Moderna Stock Falls on $2B Notes Deal: Is the Cancer Rally Still Intact?

TradingKey
·
Aug 28

Argus Research Upgrades Moderna to Buy From Hold, $180 Price Target

MT Newswires Live
·
Aug 28

Moderna Announces Pricing of Upsized $2.6 Billion Offering of Convertible Senior Notes

Reuters
·
Aug 28

Moderna Price Target Announced at $180.00/Share by Argus Research

Dow Jones
·
Aug 28

U.S. Stocks on the MOVE-Cytokinetics, Moderna, Ulta Beauty

Reuters
·
Aug 28

Success After a Century of Failures: Inside Moderna and Merck's Cancer Vaccine Breakthrough

Reuters
·
Aug 28